Lee John Tayu, Ishida Marie, Haregu Tilahun, Pati Sanghamitra, Zhao Yang, Palladino Raffaele, Anindya Kanya, Atun Rifat, Oldenburg Brian, Marthias Tiara
Department of Primary Care and Public Health, Imperial College London, London, United Kingdom.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Front Med (Lausanne). 2023 May 17;10:1151310. doi: 10.3389/fmed.2023.1151310. eCollection 2023.
The inverse relationships between chronic disease multimorbidity and health-related quality of life (HRQoL) have been well-documented in the literature. However, the mechanism underlying this relationship remains largely unknown. This is the first study to look into the potential role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL.
This study utilized three recent waves of nationally representative longitudinal Household, Income, and Labor Dynamics in Australia (HILDA) surveys from 2009 to 2017 ( = 6,814). A panel mediation analysis was performed to assess the role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL. The natural direct effect (NDE), indirect effect (NIE), marginal total effect (MTE), and percentage mediated were used to calculate the levels of the mediation effect.
This study found that functional limitation is a significant mediator in the relationship between multimorbidity and HRQoL. In the logistic regression analysis, the negative impact of multimorbidity on HRQoL was reduced after functional limitation was included in the regression model. In the panel mediation analysis, our results suggested that functional limitation mediated ~27.2% ( < 0.05) of the link between multimorbidity and the composite SF-36 score for HRQoL. Functional limitation also mediated the relationship between the number of chronic conditions and HRQoL for each of the eight SF-36 dimensions, with a proportion mediated ranging from 18.4 to 28.8% ( < 0.05).
Functional status has a significant impact on HRQoL in multimorbid patients. Treatment should concentrate on interventions that improve patients' functioning and mitigate the negative effects of multimorbidity.
慢性病共病与健康相关生活质量(HRQoL)之间的负相关关系在文献中已有充分记载。然而,这种关系背后的机制在很大程度上仍不明确。这是第一项研究功能限制作为共病与HRQoL之间关系中介的潜在作用的研究。
本研究利用了2009年至2017年澳大利亚全国代表性纵向家庭、收入和劳动力动态(HILDA)调查的最近三轮数据(n = 6814)。进行了面板中介分析,以评估功能限制作为共病与HRQoL之间关系中介的作用。自然直接效应(NDE)、间接效应(NIE)、边际总效应(MTE)和中介百分比用于计算中介效应水平。
本研究发现功能限制是共病与HRQoL之间关系的重要中介。在逻辑回归分析中,将功能限制纳入回归模型后,共病对HRQoL的负面影响有所降低。在面板中介分析中,我们的结果表明,功能限制介导了共病与HRQoL综合SF - 36评分之间约27.2%的联系(p < 0.05)。功能限制还介导了慢性病数量与HRQoL在SF - 36八个维度中每个维度之间的关系,中介比例在18.4%至28.8%之间(p < 0.05)。
功能状态对多病患者的HRQoL有显著影响。治疗应集中于改善患者功能并减轻共病负面影响的干预措施。